National HealthCare Corporation (NHC) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
National HealthCare Corporation stock (NHC) is currently trading at $161.99. National HealthCare Corporation PE ratio is 19.54. National HealthCare Corporation PS ratio (Price-to-Sales) is 1.63. Analyst consensus price target for NHC is $6.15. WallStSmart rates NHC as Underperform.
- NHC PE ratio analysis and historical PE chart
- NHC PS ratio (Price-to-Sales) history and trend
- NHC intrinsic value — DCF, Graham Number, EPV models
- NHC stock price prediction 2025 2026 2027 2028 2029 2030
- NHC fair value vs current price
- NHC insider transactions and insider buying
- Is NHC undervalued or overvalued?
- National HealthCare Corporation financial analysis — revenue, earnings, cash flow
- NHC Piotroski F-Score and Altman Z-Score
- NHC analyst price target and Smart Rating
National HealthCare Corporation
📊 No data available
Try selecting a different time range
NHC Intrinsic Value Analysis for Value Investors
Benjamin Graham Formula · National HealthCare Corporation (NHC)
NHC trades 282% above its Graham fair value of $44.06, indicating the stock may be overvalued at current levels.
Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.
Smart Analysis
National HealthCare Corporation (NHC) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, price/sales, institutional own.. Concerns around operating margin and eps growth. Fundamentals are solid but monitor weak areas for improvement.
National HealthCare Corporation (NHC) Key Strengths (3)
Growing significantly faster than its price suggests
Paying $1.63 for every $1 of annual revenue
59.15% held by institutions, strong professional interest
Supporting Valuation Data
National HealthCare Corporation (NHC) Areas to Watch (7)
Earnings declining -8.40%, profits shrinking
Very thin margins with limited operational efficiency
Thin profit margins with limited profitability
Small-cap company with higher risk but more growth potential
Moderate profitability with room for improvement
Fairly priced relative to book value
Solid revenue growth at 12.50% per year
Supporting Valuation Data
National HealthCare Corporation (NHC) Detailed Analysis Report
Overall Assessment
This company scores 54/100 in our Smart Analysis, earning a C- grade. Out of 10 metrics analyzed, 3 register as strengths (avg 8.7/10) while 7 fall into concern territory (avg 4.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on PEG Ratio, Price/Sales, Institutional Own.. Valuation metrics including PEG Ratio (0.82), Price/Sales (1.63) suggest the stock is attractively priced.
The Bear Case
The primary concerns are EPS Growth, Operating Margin, Profit Margin. Some valuation metrics including Price/Book (2.31) suggest expensive pricing. Growth concerns include Revenue Growth at 12.50%, EPS Growth at -8.40%, which may limit upside. Profitability pressure is visible in Return on Equity at 10.10%, Operating Margin at 7.94%, Profit Margin at 6.75%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether EPS Growth improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 10.10% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 12.50% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (PEG Ratio, Price/Sales) and negatives (EPS Growth, Operating Margin). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
NHC Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
NHC's Price-to-Sales ratio of 1.63x trades at a 45% premium to its historical average of 1.12x (96th percentile). The current valuation is 5% below its historical high of 1.72x set in Mar 2026, and 132% above its historical low of 0.7x in Sep 2011.
WallStSmart Analysis Synopsis
Data-driven financial summary for National HealthCare Corporation (NHC) · HEALTHCARE › MEDICAL CARE FACILITIES
The Big Picture
National HealthCare Corporation operates as a stable business with moderate growth and solid fundamentals. Revenue reached 1.5B with 13% growth year-over-year. Profit margins are thin at 6.8%, typical for companies in this phase that are reinvesting heavily in growth.
Key Findings
ROE of 1010.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
Generating 6M in free cash flow and 17M in operating cash flow. Earnings are translating into actual cash generation.
What to Watch Next
Margin expansion: can National HealthCare Corporation push profit margins above 15% as the business scales?
Dividend sustainability with a current yield of 193.0%. Watch payout ratio and free cash flow coverage.
Sector dynamics: monitor MEDICAL CARE FACILITIES industry trends, competitive moves, and regulatory changes that could impact National HealthCare Corporation.
Bottom Line
National HealthCare Corporation offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About National HealthCare Corporation(NHC)
NYSE MKT
HEALTHCARE
MEDICAL CARE FACILITIES
USA
National HealthCare Corporation operates, manages, and provides services to skilled nursing facilities, assisted living facilities, independent living facilities, home health programs, and a behavioral health hospital. The company is headquartered in Murfreesboro, Tennessee.